糖尿病与胰岛移植中前胰岛淀粉样多肽(1-48)的检测
该研究开发了一种免疫分析法检测人血浆中前胰岛淀粉样多肽(proIAPP1-48),并比较了1型糖尿病、2型糖尿病、胰岛移植受者和健康对照者的proIAPP1-48与成熟IAPP比值。结果显示1型糖尿病胰岛移植受者proIAPP1-48免疫反应性显著升高,1型糖尿病儿童和成人成熟IAPP水平降低但proIAPP1-48与总IAPP比值升高。作者认为该比值可能作为β细胞应激和功能障碍的生物标志物。
要点
- 建立检测人血浆proIAPP1-48的免疫分析法,检测限0.18±0.06 pM,与完整proIAPP1-67交叉反应<15%。
- 健康人血浆proIAPP1-48免疫反应性为1.5±0.2 pM,proIAPP1-48与总IAPP比值为0.28±0.03。
- 1型糖尿病胰岛移植受者proIAPP1-48免疫反应性显著升高,1型糖尿病儿童和成人成熟IAPP降低但比值升高。
核心结论
- 1型糖尿病和胰岛移植中的β细胞对proIAPP1-48中间体的加工受损。
- proIAPP1-48与IAPP免疫反应性的比值可能作为β细胞应激和功能障碍的生物标志物。
研究设计与样本
- 开发免疫分析法检测人血浆proIAPP1-48,并测定1型糖尿病、2型糖尿病、胰岛移植受者和健康对照者的proIAPP1-48与成熟IAPP比值。
主要发现
- proIAPP1-48免疫分析法检测限为0.18±0.06 pM,与完整proIAPP1-67交叉反应<15%。
- 健康个体血浆proIAPP1-48免疫反应性浓度为1.5±0.2 pM,proIAPP1-48与总IAPP比值为0.28±0.03。
- 2型糖尿病受试者血浆proIAPP1-48免疫反应性浓度无显著差异。
- 1型糖尿病胰岛移植受者血浆proIAPP1-48免疫反应性显著升高。
- 1型糖尿病儿童和成人较年龄匹配对照成熟IAPP水平降低,但proIAPP1-48与总IAPP比值升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Islet amyloid is a feature of β-cell failure in type 2 diabetes (T2D) and type 1 diabetes (T1D) recipients of islet transplants. Islet amyloid contains islet amyloid polypeptide (IAPP; amylin), a circulating peptide that is produced in β cells by processing of its precursor, proIAPP1-67, via an intermediate form, proIAPP1-48. Elevated proinsulin to C-peptide ratios in the plasma of persons with diabetes suggest defects in β-cell prohormone processing. OBJECTIVE: Determine whether plasma levels of precursor forms of IAPP are elevated in diabetes. DESIGN, SETTING, AND PATIENTS: We developed an immunoassay to detect proIAPP1-48 in human plasma, and we determined the ratio of proIAPP1-48 to mature IAPP in subjects with T1D, T2D, recipients of islet transplants, and healthy controls. RESULTS: The proIAPP1-48 immunoassay had a limit of detection of 0.18 ± 0.06 pM and cross-reactivity with intact proIAPP1-67 <15%. Healthy individuals had plasma concentrations of proIAPP1-48 immunoreactivity of 1.5 ± 0.2 pM and a proIAPP1-48 to total IAPP ratio of 0.28 ± 0.03. Plasma concentrations of proIAPP1-48 immunoreactivity were not significantly different in subjects with T2D but were markedly increased in T1D recipients of islet transplants. Children and adults with T1D had reduced mature IAPP levels relative to age-matched controls but an elevated ratio of proIAPP1-48 to total IAPP. CONCLUSION: The β cells in T1D and islet transplants have impaired processing of the proIAPP1-48 intermediate. The ratio of proIAPP1-48-to-IAPP immunoreactivity may have value as a biomarker of β-cell stress and dysfunction.
引用
- Courtade JA, Klimek-Abercrombie AM, Chen YC, et al. Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet Transplants. J Clin Endocrinol Metab. 2017. PMID: 28368485. doi:10.1210/jc.2016-2773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。